Liv Hospital health content is written by a content specialist, verified by an independent expert and medically approved by a physician in the relevant field.
- Mustafa ÇelikWriter
- Lamiya GurbanovaFact-checker
- Op. MD. Ulviye HanlıMedical reviewer
Mustafa Çelik is a versatile Engineer and Content Writer who bridges the…
View author profile →
Dr. Lamiya Gurbanova is a physician who completed her specialization training in…
View profile →
Approved this content for clinical accuracy in their specialty.
View doctor profile →We review our content at regular intervals and update it whenever new research or a change in clinical guidelines requires it.
Overview
What Is Cervical Dysplasia?
Cervical dysplasia means abnormal, precancerous cells are growing on the surface of the cervix. It most often develops after a persistent infection with a high-risk type of human papillomavirus (HPV). Cervical dysplasia is not the same as cervical cancer, and many people have no symptoms. Routine screening can find these abnormal cervical cells before they cause noticeable problems.
How It's Diagnosed
How Cervical Dysplasia Is Diagnosed
HPV testing and cervical cytology, such as a Pap test, can identify people who need further evaluation even when they feel well. If a screening result is abnormal, follow-up testing helps determine whether abnormal cells are present and how extensive they are.
- Cervical screening: An HPV test, Pap test, or combination of tests looks for high-risk HPV or abnormal cervical cells.
- Colposcopy: A clinician uses a magnifying instrument to examine the cervix more closely and identify areas that may need sampling.
- Biopsy: A small sample of cervical tissue may be removed and examined under a microscope.
- Pathology results: The report may use cervical intraepithelial neoplasia (CIN) terminology to grade the severity of the dysplasia.
| Grade | What it means | Typical management focus |
|---|---|---|
| CIN 1 | Low-grade changes affecting the lower portion of the cervical surface | Often monitored because many regress |
| CIN 2 | Moderate-grade changes involving more of the cervical surface | Observation or treatment depending on individual factors |
| CIN 3 | High-grade changes involving most or all of the surface thickness | Usually treated because progression risk is higher |
Causes
What Causes Cervical Dysplasia?
Most cervical dysplasia develops after persistent infection with a high-risk type of human papillomavirus. When high-risk HPV remains in cervical cells, it can interfere with the normal controls that regulate cell growth and repair. Over time, this may lead to dysplasia of the cervix and, in some cases, higher-grade changes.
Risk Factors
Risk Factors for Cervical Dysplasia
- Persistent infection with a high-risk HPV type is the main associated factor and is only partly modifiable through vaccination, safer-sex practices, and screening.
- Smoking or exposure to tobacco smoke is a modifiable factor that may make it harder for the body to clear HPV.
- A weakened immune system is partly modifiable in some situations, although underlying illnesses or necessary medicines may not be avoidable.
- A history of other sexually transmitted infections is partly modifiable through prevention and testing, but past infections cannot be changed.
- Long-term use of certain hormonal contraceptives may be relevant to individual counseling and should be discussed with a clinician rather than stopped without advice.
- Older age or prior abnormal cervical screening results are non-modifiable factors that can affect follow-up decisions.
- Limited access to HPV vaccination or routine cervical screening is a partly modifiable access-related factor that can delay prevention or detection.
Having a risk factor does not mean cervical dysplasia will develop. People without obvious risk factors can still have abnormal screening results, which is why recommended vaccination and screening remain important.
Complications
Possible Complications of Cervical Dysplasia
- Progression to cervical cancer: Untreated high-grade dysplasia can sometimes progress to invasive cancer.
- Return of abnormal cells after treatment: Dysplasia can recur, particularly if high-risk HPV persists, so surveillance remains important.
- Emotional distress after an abnormal result: Worry about dysplasia and cancer is common, even though an abnormal result does not automatically mean cancer.
- Bleeding, infection, or cervical changes after a procedure: These effects are uncommon but can occur after biopsy or excisional treatment.
RISK CONTEXT
Follow-up matters
Prompt follow-up substantially lowers the chance that cervical dysplasia will progress to invasive cancer because changes can be monitored or treated. No follow-up plan can guarantee an individual outcome, so keep recommended appointments and discuss any concerns with your clinician.
Treatment & Management
Treatment and Management of Cervical Dysplasia
Observation and repeat testing
CIN 1 and some carefully selected CIN 2 changes may be monitored rather than treated immediately because they can regress or remain stable. Monitoring may include repeat HPV testing, Pap testing, or colposcopy based on age, pregnancy status, previous results, and current clinical guidance.
Procedures for persistent or high-grade changes
- Loop electrosurgical excision procedure: LEEP, also called LLETZ, removes abnormal tissue with a thin electrically heated wire loop and may provide a tissue sample for examination.
- Cone biopsy: This procedure removes a cone-shaped piece of the cervix and may be recommended when the abnormal area extends farther into the cervical canal or needs more complete assessment.
- Ablation such as cryotherapy or laser treatment: These approaches destroy selected abnormal tissue without removing a specimen in the same way as excision, when they are appropriate.
- Post-treatment surveillance: Follow-up HPV or Pap testing and examination help check for remaining or returning dysplasia; pregnancy and fertility considerations should be discussed before treatment.
Prevention & Screening
Cervical Dysplasia Prevention and Screening
HPV VACCINATION
Vaccination lowers the risk from HPV types linked to cervical precancer, but it does not prevent every HPV infection and does not replace cervical screening.
CERVICAL SCREENING
HPV testing and Pap testing can detect abnormal cervical cells early, when they are often easier to monitor or treat.
- People in the recommended screening age range should follow local cervical screening guidance.
- Screening may use an HPV test, a Pap test, or both depending on age and local recommendations.
- Screening intervals depend on the test used, age, and previous results.
- An abnormal result does not automatically mean cancer but should be followed as advised.
Outlook and Prognosis
Outlook and Prognosis
Many low-grade abnormalities resolve or remain stable without immediate treatment. Persistent high-grade dysplasia is more likely to require treatment to prevent cervical cancer. The outlook depends on the pathology findings, HPV persistence, immune status, age, pregnancy plans, and whether recommended follow-up is completed.
| Finding | General outlook | Follow-up emphasis |
|---|---|---|
| CIN 1 | Often regresses | Repeat testing or examination |
| CIN 2 | May regress or persist | Individualized observation or treatment |
| CIN 3 | Higher progression risk if untreated | Treatment and close surveillance |
When Should You See a Doctor
When Should You See a Doctor?
- Contact a clinician after any abnormal HPV or Pap test result.
- Ask for help if you are unsure when a recommended colposcopy or repeat test is due.
- Seek evaluation for bleeding after sex, between periods, or after menopause.
- Seek evaluation for unusual vaginal discharge or persistent pelvic pain.
- Contact the procedure team for heavy bleeding, fever, severe pain, or other concerning symptoms after biopsy or treatment.
Branches
1 topic
Cervical Dysplasia
Gynecology & Obstetrics
